LONDON/BANGKOK (Reuters) – Health care workers in Britain and Thailand have actually begun participating in a trial to determine whether 2 anti-malarial drugs can prevent COVID-19, consisting of one that U.S. President Donald Trump states he has actually been taking.
The research study, including more than 40,000 healthcare workers across Europe, Africa, Asia and South America, seeks to identify whether chloroquine and hydroxychloroquine might play a role in the fight against the unique coronavirus.
Demand for hydroxychloroquine surged after Trump touted it in early April. He stated today he was now taking it as a preventive medication against the infection regardless of medical warnings about its use.
The lead investigators in Thailand a